192 related articles for article (PubMed ID: 15802936)
1. Adrenomedullin and leptin levels in diabetic retinopathy and retinal diseases.
Er H; Doğanay S; Ozerol E; Yürekli M
Ophthalmologica; 2005; 219(2):107-11. PubMed ID: 15802936
[TBL] [Abstract][Full Text] [Related]
2. Vitreous and plasma concentrations of apelin and vascular endothelial growth factor after intravitreal bevacizumab in eyes with proliferative diabetic retinopathy.
Qian J; Lu Q; Tao Y; Jiang YR
Retina; 2011 Jan; 31(1):161-8. PubMed ID: 20890241
[TBL] [Abstract][Full Text] [Related]
3. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
[TBL] [Abstract][Full Text] [Related]
4. Vitreous leptin levels in retinal disease.
Maberley D; Cui JZ; Matsubara JA
Eye (Lond); 2006 Jul; 20(7):801-4. PubMed ID: 16052255
[TBL] [Abstract][Full Text] [Related]
5. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
Itakura H; Kishi S; Kotajima N; Murakami M
Ophthalmology; 2004 Oct; 111(10):1880-4. PubMed ID: 15465550
[TBL] [Abstract][Full Text] [Related]
6. Elevated adrenomedullin in the vitreous of patients with proliferative vitreoretinopathy.
Udono T; Takahashi K; Takano S; Shibahara S; Tamai M
Am J Ophthalmol; 1999 Dec; 128(6):765-7. PubMed ID: 10612519
[TBL] [Abstract][Full Text] [Related]
7. Changes in adrenomedullin in patients with proliferative diabetic retinopathy.
Lu Y; Xu Y; Tang C
Curr Eye Res; 2011 Nov; 36(11):1047-52. PubMed ID: 21942228
[TBL] [Abstract][Full Text] [Related]
8. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of RAGE and its ligands in proliferative retinal disease.
Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
[TBL] [Abstract][Full Text] [Related]
10. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
[TBL] [Abstract][Full Text] [Related]
11. The Expression of GDF-15 in the Human Vitreous in the Presence of Retinal Pathologies with an Inflammatory Component.
Ilhan HD; Bilgin AB; Toylu A; Dogan ME; Apaydin KC
Ocul Immunol Inflamm; 2016; 24(2):178-83. PubMed ID: 26177355
[TBL] [Abstract][Full Text] [Related]
12. Apelin in plasma and vitreous and in fibrovascular retinal membranes of patients with proliferative diabetic retinopathy.
Tao Y; Lu Q; Jiang YR; Qian J; Wang JY; Gao L; Jonas JB
Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4237-42. PubMed ID: 20220056
[TBL] [Abstract][Full Text] [Related]
13. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease.
Murugeswari P; Shukla D; Rajendran A; Kim R; Namperumalsamy P; Muthukkaruppan V
Retina; 2008 Jun; 28(6):817-24. PubMed ID: 18536597
[TBL] [Abstract][Full Text] [Related]
14. Vitreous renin activity correlates with vascular endothelial growth factor in proliferative diabetic retinopathy.
Kanda A; Noda K; Saito W; Ishida S
Br J Ophthalmol; 2013 May; 97(5):666-8. PubMed ID: 23418197
[No Abstract] [Full Text] [Related]
15. Vitreous fluid levels of beta-amyloid((1-42)) and tau in patients with retinal diseases.
Yoneda S; Hara H; Hirata A; Fukushima M; Inomata Y; Tanihara H
Jpn J Ophthalmol; 2005; 49(2):106-8. PubMed ID: 15838725
[TBL] [Abstract][Full Text] [Related]
16. Correlation between ficolin-3 and vascular endothelial growth factor-to-pigment epithelium-derived factor ratio in the vitreous of eyes with proliferative diabetic retinopathy.
Zheng B; Li T; Chen H; Xu X; Zheng Z
Am J Ophthalmol; 2011 Dec; 152(6):1039-43. PubMed ID: 21851923
[TBL] [Abstract][Full Text] [Related]
17. Diabetic patients and retinal proliferation: an evaluation of the role of vascular endothelial growth factor (VEGF).
Nicoletti VG; Nicoletti R; Ferrara N; Meli G; Reibaldi M; Reibaldi A
Exp Clin Endocrinol Diabetes; 2003 Jun; 111(4):209-14. PubMed ID: 12845559
[TBL] [Abstract][Full Text] [Related]
18. Decreased vitreal hyaluronan levels with aging.
Itakura H; Kishi S; Kotajima N; Murakami M
Ophthalmologica; 2009; 223(1):32-5. PubMed ID: 18953185
[TBL] [Abstract][Full Text] [Related]
19. Increased osteopontin levels in the vitreous of patients with diabetic retinopathy.
Kase S; Yokoi M; Saito W; Furudate N; Ohgami K; Kitamura M; Kitaichi N; Yoshida K; Kase M; Ohno S; Uede T
Ophthalmic Res; 2007; 39(3):143-7. PubMed ID: 17505146
[TBL] [Abstract][Full Text] [Related]
20. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J
Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
